Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depigoid Grass Mix versus placebo for grass pollen allergic rhinitis/rhinoconjunctivitis
2007-004255-10Phase 3Completed
- Sponsor
- LETI Pharma
- Start
- Sep 2007
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in allergic rhinitis (AR) and allergic rhinoconjunctivitis (ARC) comparing Depigoid Grass Mix with Placebo (2 arms). Primary endpoint: Mean Total Nasal Symptom Score. Started Sep 2007; status: completed.
02
Drugs
Depigoid Grass Mix
03
Conditions
allergic rhinitis (AR)allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on 2007-004255-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004255-10.